Tevogen Bio
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $396 | $0 |
Gross Profit | -27 | -290 | -105 | |
EBITDA | -5,637 | -5,175 | -10,237 | |
EBIT | -5,664 | -5,465 | -10,342 | -9,423 |
Net Income | -5,726 | -5,503 | -10,367 | -9,444 |
Net Change In Cash | 0 | 0 | 396 | 0 |
Free Cash Flow | -3,649 | -3,189 | -3,308 | -3,047 |
Cash | 1,037 | 685 | 1,974 | 1,282 |
Basic Shares | 196,028 | 184,307 | 161,407 | 177,991 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -403 | -378 | ||
EBITDA | -13,139 | -58,892 | 4,408 | -14,988 |
EBIT | -13,543 | -59,271 | -1,183 | -14,998 |
Net Income | -10,114 | -60,477 | 4,408 | -15,596 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,998 | -8,304 | -9,134 | -5,384 |
Cash | 1,282 | 1,052 | 5,484 | 7,119 |
Basic Shares | 146,672 | 165,421 | 119,999 | 47,933 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.03 |
2025-06-30 | -$0.03 |
2025-03-31 | -$0.07 |
2024-12-31 | -$0.05 |
